Two Years to Build or Pay 200% — Which US Pharma Stocks Win?benzinga_article·2 days ago, 05:25 AMAMPH-0.79%ANIP-1.12%
Amphastar Pharmaceuticals (AMPH) Gets a Hold from J.P. MorganTip Ranks·2 days ago, 08:36 AMAMPH-0.79%
Amphastar Pharmaceuticals director Anthony T. Pierce files initial beneficial ownership statement (Form 3)PUBT·Jul 13 at 06:36 PMAMPH-0.79%
Amphastar names Anthony Pierce to board as director expands to 11 seatsPUBT·Jul 13 at 05:07 AMAMPH-0.79%
Amphastar Pharmaceuticals subsidiary receives FDA warning letter over CGMP issues at California facilityTradingView·Jul 8 at 05:03 AMAMPH-0.79%
Amphastar Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $22, Implies 1% UpsideTradingView·Jun 29 at 08:20 AMAMPH-0.79%
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Mondaybenzinga_article·Jun 29 at 07:49 AMDOCS-0.15%LQDA-3.16%
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference | AMPH Stock NewsStockTitan·May 26 at 09:00 PMAMPH-0.79%XLV+0.70%
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales OutlookMarket Beat·May 14 at 01:05 AMAMPH-0.79%IHE+0.38%
Amphastar Pharmaceuticals (NASDAQ:AMPH) Earns Neutral Rating from Piper SandlerMarket Beat·May 11 at 01:33 PMAMPH-0.79%ARKG-2.60%
